The serum levels of IL-6 and TNF-α was significantly higher following DSS treatment in the DC group than that in the BC group (p < 0.05); no significant difference was present between the DC and BC groups for IL-1β without the protection of C. butyricum (Figure 4). The gene discussed is IL6; the disease is breast cancer.